Trials / Conditions / Recurrent or Metastatic Cervical Cancer
Recurrent or Metastatic Cervical Cancer
6 registered clinical trials studyying Recurrent or Metastatic Cervical Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer NCT07051486 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Recruiting | SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer NCT06859775 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer NCT06155422 | Gang Chen (101199) | — |
| Completed | A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer NCT04680988 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Completed | A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer NCT04868708 | Akeso | Phase 2 |
| Unknown | A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer NCT04623333 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 2 |